Future Challenges and Present Ethical Considerations in the Use of Personalized Nutrition Based on Genetic Advice

Journal of the Academy of Nutrition and Dietetics

Volumn 113, Issue 11, 2013, Pages 1447-1454

  San Cristobal, Rodrigo ^a   Milagro, Fermín I ^a   Martínez, J Alfredo ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Genetic tests; Nutrigenetics; Obesity; Personalized nutrition

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; DIET; ETHICS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC TESTS; GENETICS; HUMAN; LEGAL ASPECT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENETICS; NUTRIGENOMICS; NUTRITION; OBESITY; PERSONALIZED MEDICINE; PERSONALIZED NUTRITION; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC TESTS; NUTRIGENETICS; OBESITY; PERSONALIZED NUTRITION;

ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; DIET; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE; NUTRIGENOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84885948539     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2013.05.028     Document Type: Article

References (57)

1. Hernell O., West C. Do we need personalized recommendations for infants at risk of developing disease?. Nestle Nutr Workshop Ser Pediatr Progr 2008, 62:239-249. discussion 249-252.
2. Marti A., Moreno-Aliaga M.J., Zulet A., et al. Advances in molecular nutrition: nutrigenomics and/or nutrigenetics. Nutr Hosp 2005, 20(3):157-164.
3. Ng P.C., Murray S.S., Levy S., et al. An agenda for personalized medicine. Nature 2009, 461(7265):724-726.
4. DeBusk R. Diet-related disease, nutritional genomics, and food and nutrition professionals. JAm Diet Assoc 2009, 109(3):410-413.
5. Bouchard C., Ordovas J.M. Fundamentals of nutrigenetics and nutrigenomics. Prog Mol Biol Transl Sci 2012, 108:1-15.
6. Kapka-Skrzypczak L., Niedzwiecka J., Cyranka M., et al. Nutrigenomics-Perspectives of personalized nutrition. Pediatr Endocrinol Diabetes Metab 2011, 17(4):222-226.
7. Fenech M., El-Sohemy A., Cahill L., et al. Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. JNutrigenet Nutrigenomics 2011, 4(2):69-89.
8. Flanagan S.E., Xie W., Caswell R., et al. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet 2013, 92(1):131-136.
9. Jalba M.S., Rhoads G.G., Demissie K. Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: A meta-analysis. Obesity (Silver Spring) 2008, 16(9):2096-2106.
10. Larsen L.H., Angquist L., Vimaleswaran K.S., et al. Analyses of single nucleotide polymorphisms in selected nutrient-sensitive genes in weight-regain prevention: The DIOGENES study. Am J Clin Nutr 2012, 95(5):1254-1260.
11. Costanza M.C., Beer-Borst S., James R.W., et al. Consistency between cross-sectional and longitudinal SNP: Blood lipid associations. Eur J Epidemiol 2012, 27(2):131-138.
12. Scuteri A., Sanna S., Chen W.M., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3(7):e115.
13. Razquin C., Marti A., Martinez J.A. Evidences on three relevant obesogenes: MC4R, FTO and PPARgamma. Approaches for personalized nutrition. Mol Nutr Food Res 2011, 55(1):136-149.
14. Rasmussen-Torvik L.J., Alonso A., Li M., et al. Impact of repeated measures and sample selection on genome-wide association studies of fasting glucose. Genet Epidemiol 2010, 34(7):665-673.
15. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum Mutat 2000, 16(5):377-385.
16. Rung J., Cauchi S., Albrechtsen A., et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009, 41(10):1110-1115.
17. Marques-Pinheiro A., Marduel M., Rabes J.P., et al. Afourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1. Eur J Hum Genet 2010, 18(11):1236-1242.
18. Dougkas A, Yaqoob P, Givens DI, et al. The impact of obesity-related SNP on appetite and energy intake [published online ahead of print February 22, 2013]. Br J Nutr. http://dx.doi.org/10.1017/S0007114513000147.
19. Wheeler E., Huang N., Bochukova E.G., et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat Genet 2013, 45(5):513-517.
20. Scherag A., Jarick I., Grothe J., et al. Investigation of a genome wide association signal for obesity: Synthetic association and haplotype analyses at the melanocortin 4 receptor gene locus. PLoS One 2010, 5(11):e13967.
21. Xi B, Zhao X, Chandak GR, et al. Influence of obesity on association between genetic variants identified by genome-wide association studies and hypertension risk in Chinese children [published online ahead of print April 16, 2013]. Am J Hypertens. http://dx.doi.org/10.1093/ajh/hpt046.
22. Olza J., Gil-Campos M., Leis R., et al. Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children. Peptides 2013, 45:22-27.
23. Lee Y.S., Challis B.G., Thompson D.A., et al. APOMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 2006, 3(2):135-140.
24. Volckmar A.L., Bolze F., Jarick I., et al. Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants. BMC Med Genomics 2012, 5:65.
25. Qian L., Xu K., Xu X., et al. UCP2 -866G/A, Ala55Val and UCP3 -55C/T polymorphisms in association with obesity susceptibility-A meta-analysis study. PLoS One 2013, 8(4):e58939.
26. Tan A., Sun J., Xia N., et al. Agenome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population. Hum Mol Genet 2012, 21(7):1658-1664.
27. Johnson A.D., Bhimavarapu A., Benjamin E.J., et al. CLIA-tested genetic variants on commercial SNP arrays: Potential for incidental findings in genome-wide association studies. Genet Med 2010, 12(6):355-363.
28. Garcia-Rios A., Delgado-Lista J., Perez-Martinez P., et al. Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism. Atherosclerosis 2011, 218(2):416-422.
29. Asselbergs F.W., Guo Y., van Iperen E.P., et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012, 91(5):823-838.
30. Martinez J.A., Cordero P., Campion J., et al. Interplay of early-life nutritional programming on obesity, inflammation and epigenetic outcomes. Proc Nutr Soc 2012, 71(2):276-283.
31. Moleres A., Rendo-Urteaga T., Zulet M.A., et al. Obesity susceptibility loci on body mass index and weight loss in Spanish adolescents after a lifestyle intervention. JPediatr 2012, 161(3):466-470 e2.
32. Austin S.E., Hegele R.A. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk. Can J Cardiol 2011, 27(6):682-684.
33. Loos R.J. Recent progress in the genetics of common obesity. Br J Clin Pharmacol 2009, 68(6):811-829.
34. Vakili S., Caudill M.A. Personalized nutrition: Nutritional genomics as a potential tool for targeted medical nutrition therapy. Nutr Rev 2007, 65(7):301-315.
35. Behar D.M., Rosset S., Blue-Smith J., et al. The Genographic Project public participation mitochondrial DNA database. PLoS Genet 2007, 3(6):e104.
36. Langford A.T., Resnicow K., Roberts J.S., et al. Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: Sociodemographic and numeracy correlates. JGenet Couns 2012, 21(3):440-447.
37. Castle D., DeBusk R. The electronic health record, genetic information, and patient privacy. JAm Diet Assoc 2008, 108(8):1372-1374.
38. Bouwman L., Te Molder H., Hiddink G. Patients, evidence and genes: An exploration of GPs' perspectives on gene-based personalized nutrition advice. Fam Pract 2008, 25(suppl 1):i116-i122.
39. Roosen J., Bruhn M., Mecking R.A., et al. Consumer demand for personalized nutrition and functional food. Int J Vitam Nutr Res 2008, 78(6):269-274.
40. Food4Me. [cited 2013]. Accessed May 2, 2013. http://www.food4me.org.
41. Young S. NIH announces database for genetic test information. February 29, 2012 edition. Accessed May 2, 2013. http://blogs.nature.com/news/2012/02/nih-announces-database-for-genetic-test-information.html.
42. Samuel G.N., Jordens C.F., Kerridge I. Direct-to-consumer personal genome testing: Ethical and regulatory issues that arise from wanting to 'know' your DNA. Intern Med J 2010, 40(3):220-224.
43. Markowitz S.M., Park E.R., Delahanty L.M., et al. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care 2011, 34(3):568-573.
44. Sanderson S.C., Persky S., Michie S. Psychological and behavioral responses to genetic test results indicating increased risk of obesity: Does the causal pathway from gene to obesity matter?. Public Health Genomics 2010, 13(1):34-47.
45. Andreasen C.H., Andersen G. Gene-environment interactions and obesity-Further aspects of genomewide association studies. Nutrition 2009, 25(10):998-1003.
46. Marti A., Goyenechea E., Martinez J.A. Nutrigenetics: A tool to provide personalized nutritional therapy to the obese. World Rev Nutr Diet 2010, 101:21-33.
47. Grimble R.F. The true cost of in-patient obesity: Impact of obesity on inflammatory stress and morbidity. Proc Nutr Soc 2010, 69(4):511-517.
48. Campion J., Milagro F., Martinez J.A. Epigenetics and obesity. Prog Mol Biol Transl Sci 2010, 94:291-347.
49. Hanson M., Godfrey K.M., Lillycrop K.A., et al. Developmental plasticity and developmental origins of non-communicable disease: Theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 2011, 106(1):272-280.
50. Rakyan V.K., Down T.A., Balding D.J., et al. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12(8):529-541.
51. Milagro F.I., Mansego M.L., De Miguel C., et al. Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives. Mol Aspects Med 2013, 34(4):782-812.
52. Centers for Disease Control and Prevention. Clinical Laboratory Improvement Amendments (CLIA). 2012 [cited 2013 February]. Accessed May 2, 2013. http://wwwn.cdc.gov/clia/.
53. Borry P., van Hellemondt R.E., Sprumont D., et al. Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 2012, 20(7):715-721.
54. Skirton H., Goldsmith L., Jackson L., et al. Direct to consumer genetic testing: A systematic review of position statements, policies and recommendations. Clin Genet 2012, 82(3):210-218.
55. EuroGentest, Center for Human Genetics. [cited February 2013]. Accessed May 2, 2013. http://www.eurogentest.org/web/index.xhtml.
56. NUGO, Nutrigenomics Organisation. 2010 [cited February 2013]. Accessed May 2, 2013. http://www.nugo.org/everyone.
57. International Society of Nutrigenetics/Nutrigenomics (ISNN). 2013 [cited February 2013]. Accessed May 2, 2013. http://www.isnn.info/index.html.